The key aim was To judge the efficacy in the vaccine versus placebo in reducing cocaine use. Secondary objectives incorporated confirming vaccine immunogenicity via IgG anti-cocaine antibody amounts and assessing the security and tolerability of vaccination through a 20 7 days study and at 24 7 days observe-up. Your browser https://tonyx661lzl4.vigilwiki.com/user